{"database": "lobbying", "table": "lobbying_activities", "rows": [[959042, "b32294fd-a7ed-49e7-8977-f2b61409eac4", "Q2", "THE PETRIZZO GROUP, INC.", 305932, "FATE THERAPEUTICS, INC.", 2010, "second_quarter", "MED", "Advocated for federal funding in the FY 2011 Defense Appropriations to advance from basic research to clinical readiness a first generation stem cell medicine to restore hearing, eyesight, and bone fractures by using the fundemental biological mechanisms that guide cell fate to develop innovative therapeutics.  Fate's research and drug development focuses on modulating adult stem cell biology to treat disease and improve health.", "HOUSE OF REPRESENTATIVES,SENATE", 25000, null, 0, 0, "2010-07-17T14:29:59.563000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["959042"], "units": {}, "query_ms": 0.4039680352434516, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}